Literature DB >> 12781597

Pulse width is associated with cognitive decline after thalamic stimulation for essential tremor.

Steven Paul Woods1, Julie A Fields, Kelly E Lyons, Rajesh Pahwa, Alexander I Tröster.   

Abstract

The present study sought to identify predictors of cognitive decline after thalamic deep brain stimulation (DBS) for essential tremor (ET). Twenty-seven patients (55%) with ET demonstrated mild cognitive decrements relative to pre-surgical baseline (ET-D), whereas 22 patients (45%) were classified as neuropsychologically stable (ET-S). The ET-D and ET-S groups were comparable in terms of baseline demographic, disease, and neuropsychological characteristics, as well as post-surgical motor outcomes. However, the ET-D group had significantly higher pulse width (PW) stimulator settings, and a greater proportion of ET-D than ET-S patients underwent left in comparison to right thalamic stimulation. A subsequent step-wise discriminant function analysis revealed that disease onset after age 37 years and higher PW settings (>or=120 micros) were the strongest predictors of post-surgical cognitive decline in this sample. Findings indicate that although relatively higher PW settings might afford optimal tremor control in some patients, the corresponding risk of mild, probably often subclinical, cognitive morbidity must be weighed accordingly.

Entities:  

Mesh:

Year:  2003        PMID: 12781597     DOI: 10.1016/s1353-8020(03)00014-2

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  8 in total

Review 1.  Limbic, associative, and motor territories within the targets for deep brain stimulation: potential clinical implications.

Authors:  Atchar Sudhyadhom; Frank J Bova; Kelly D Foote; Christian A Rosado; Lindsey Kirsch-Darrow; Michael S Okun
Journal:  Curr Neurol Neurosci Rep       Date:  2007-07       Impact factor: 5.081

2.  Subcortical roles in lexical task processing: Inferences from thalamic and subthalamic event-related potentials.

Authors:  Hannes O Tiedt; Felicitas Ehlen; Lea K Krugel; Andreas Horn; Andrea A Kühn; Fabian Klostermann
Journal:  Hum Brain Mapp       Date:  2016-09-20       Impact factor: 5.038

3.  Neural selectivity, efficiency, and dose equivalence in deep brain stimulation through pulse width tuning and segmented electrodes.

Authors:  Collin J Anderson; Daria Nesterovich Anderson; Stefan M Pulst; Christopher R Butson; Alan D Dorval
Journal:  Brain Stimul       Date:  2020-04-09       Impact factor: 8.955

4.  Neuropsychological outcomes after thalamic deep brain stimulation for essential tremor.

Authors:  Kaltra Dhima; Julia Biars; Efstathios Kondylis; Sean Nagel; Xin Xin Yu; Darlene P Floden
Journal:  Parkinsonism Relat Disord       Date:  2021-10-27       Impact factor: 4.891

5.  Cognitive effects of deep brain stimulation for essential tremor: evaluation at 1 and 6 years.

Authors:  Ines A Heber; Volker A Coenen; Kathrin Reetz; Jörg B Schulz; Anke Hoellig; Bruno Fimm; Martin Kronenbuerger
Journal:  J Neural Transm (Vienna)       Date:  2013-05-07       Impact factor: 3.575

6.  Cognitive Outcomes for Essential Tremor Patients Selected for Thalamic Deep Brain Stimulation Surgery Through Interdisciplinary Evaluations.

Authors:  Jacob D Jones; Tatiana Orozco; Dawn Bowers; Wei Hu; Zakia Jabarkheel; Shannon Chiu; Adolfo Ramirez-Zamora; Kelly Foote; Michael S Okun; Aparna Wagle Shukla
Journal:  Front Hum Neurosci       Date:  2020-12-11       Impact factor: 3.169

7.  Thalamic but Not Subthalamic Neuromodulation Simplifies Word Use in Spontaneous Language.

Authors:  Hannes Ole Tiedt; Felicitas Ehlen; Michelle Wyrobnik; Fabian Klostermann
Journal:  Front Hum Neurosci       Date:  2021-05-20       Impact factor: 3.169

8.  Purkinje cell misfiring generates high-amplitude action tremors that are corrected by cerebellar deep brain stimulation.

Authors:  Amanda M Brown; Joshua J White; Meike E van der Heijden; Joy Zhou; Tao Lin; Roy V Sillitoe
Journal:  Elife       Date:  2020-03-17       Impact factor: 8.140

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.